Cargando…
Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin
Psoriasis is one of the most common human skin disorders. Although its pathogenesis is complex and not completely know, the hyperactivation of the immune system seem to have a key role. In this regard, among the most effective systemic therapeutics used in psoriasis, we find cyclosporine, an immunos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435943/ https://www.ncbi.nlm.nih.gov/pubmed/32748846 http://dx.doi.org/10.3390/molecules25153535 |
_version_ | 1783572439874142208 |
---|---|
author | Trombino, Sonia Servidio, Camilla Laganà, Annarita Stella Conforti, Filomena Marrelli, Mariangela Cassano, Roberta |
author_facet | Trombino, Sonia Servidio, Camilla Laganà, Annarita Stella Conforti, Filomena Marrelli, Mariangela Cassano, Roberta |
author_sort | Trombino, Sonia |
collection | PubMed |
description | Psoriasis is one of the most common human skin disorders. Although its pathogenesis is complex and not completely know, the hyperactivation of the immune system seem to have a key role. In this regard, among the most effective systemic therapeutics used in psoriasis, we find cyclosporine, an immunosuppressive medication. However, one of the major problems associated with the use of cyclosporine is the occurrence of systemic side effects such as nephrotoxicity, hypertension, etc. The present work fits in this context and its aim is the design of suitable platforms for cyclosporine topical release in psoriasis treatment. The main objective is to achieve local administration of cyclosporine in order to reduce its systemic absorption and, consequently, its side effects. In order to improve dermal penetration, solid lipid nanoparticles (SLNs) are used as carriers, due to their lipophilicity and occlusive properties, and naringenin and linolenic acid are chosen, due to their properties, as starting materials for SLNs design. In order to have dermatological formulations and further modulate drug release, SLNs are incorporated in several topical vehicles obtaining gels with different degree of lipophilicity. Potential applications for psoriasis treatment were evaluated by considering the encapsulation efficiency, release profiles, in vitro skin permeation, and anti-inflammatory effects. |
format | Online Article Text |
id | pubmed-7435943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74359432020-08-24 Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin Trombino, Sonia Servidio, Camilla Laganà, Annarita Stella Conforti, Filomena Marrelli, Mariangela Cassano, Roberta Molecules Article Psoriasis is one of the most common human skin disorders. Although its pathogenesis is complex and not completely know, the hyperactivation of the immune system seem to have a key role. In this regard, among the most effective systemic therapeutics used in psoriasis, we find cyclosporine, an immunosuppressive medication. However, one of the major problems associated with the use of cyclosporine is the occurrence of systemic side effects such as nephrotoxicity, hypertension, etc. The present work fits in this context and its aim is the design of suitable platforms for cyclosporine topical release in psoriasis treatment. The main objective is to achieve local administration of cyclosporine in order to reduce its systemic absorption and, consequently, its side effects. In order to improve dermal penetration, solid lipid nanoparticles (SLNs) are used as carriers, due to their lipophilicity and occlusive properties, and naringenin and linolenic acid are chosen, due to their properties, as starting materials for SLNs design. In order to have dermatological formulations and further modulate drug release, SLNs are incorporated in several topical vehicles obtaining gels with different degree of lipophilicity. Potential applications for psoriasis treatment were evaluated by considering the encapsulation efficiency, release profiles, in vitro skin permeation, and anti-inflammatory effects. MDPI 2020-08-02 /pmc/articles/PMC7435943/ /pubmed/32748846 http://dx.doi.org/10.3390/molecules25153535 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Trombino, Sonia Servidio, Camilla Laganà, Annarita Stella Conforti, Filomena Marrelli, Mariangela Cassano, Roberta Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title | Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title_full | Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title_fullStr | Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title_full_unstemmed | Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title_short | Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin |
title_sort | viscosified solid lipidic nanoparticles based on naringenin and linolenic acid for the release of cyclosporine a on the skin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435943/ https://www.ncbi.nlm.nih.gov/pubmed/32748846 http://dx.doi.org/10.3390/molecules25153535 |
work_keys_str_mv | AT trombinosonia viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin AT servidiocamilla viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin AT laganaannaritastella viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin AT confortifilomena viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin AT marrellimariangela viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin AT cassanoroberta viscosifiedsolidlipidicnanoparticlesbasedonnaringeninandlinolenicacidforthereleaseofcyclosporineaontheskin |